DNA vaccines for biodefense

Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults

(2010) Wendy A. Keitel et al.   Human vaccines & immunotherapeutics

Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses

(2009) Shuchi Midha et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Development and Characterization of a Mouse Model for Marburg Hemorrhagic Fever

(2009) K. L. Warfield et al.   JOURNAL OF VIROLOGY

Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus

(2009) T. W. Geisbert et al.   JOURNAL OF VIROLOGY

Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine

(2009) Jason S. Richardson et al.   PLoS One

Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine

(2009) Lesley C. Dupuy et al.   VACCINE

Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization

(2009) Kaori Shinoda et al.   Virology Journal

Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats

(2009) Jonathan S. Towner et al.   PLoS Pathogens

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

(2008) D. L. Swenson et al.   Clinical and Vaccine Immunology

Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies

(2008) Joseph W. Golden et al.   VACCINE

Potentiation of an anthrax DNA vaccine with electroporation

(2008) A. Luxembourg et al.   VACCINE

Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine

(2008) Joseph W. Golden et al.   VIROLOGY

Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda

(2008) Jonathan S. Towner et al.   PLoS Pathogens

Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates

(2008) Thomas W. Geisbert et al.   PLoS Pathogens

Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens

(2007) Pavlo Sakhatskyy et al.   VIROLOGY